Similar articles

• [Aspirin use in patients with diabetes mellitus].

  González-Clemente JM, Barahona MJ, Giménez-Pérez G, Mauricio D. González-Clemente JM, et al. Med Clin (Barc). 2004 Jul 10;123(6):238-9; author reply 239. doi: 10.1016/s0025-7753(04)74474-7. Med Clin (Barc). 2004. PMID: 15282084 Spanish. No abstract available.
• [Aspirin use in patients with diabetes mellitus].

  Barquero Romero J, Masero Carretero A, Pérez Miranda M. Barquero Romero J, et al. Med Clin (Barc). 2004 Jul 10;123(6):237; author reply 239. doi: 10.1016/s0025-7753(04)74472-3. Med Clin (Barc). 2004. PMID: 15282082 Spanish. No abstract available.
• [Aspirin use in patients with diabetes mellitus].

  Sicras Mainar A, Ruiz Riera R, Frías Garrido X, Navarro Artieda R. Sicras Mainar A, et al. Med Clin (Barc). 2004 Jul 10;123(6):237; author reply 239. Med Clin (Barc). 2004. PMID: 15282081 Spanish. No abstract available.
• [Should we treat all diabetic patients with aspirin in primary prevention?].

  Righetti A, De Moerloose P, Philippe J. Righetti A, et al. Rev Med Suisse. 2005 Jun 1;1(22):1500-4. Rev Med Suisse. 2005. PMID: 16025889 Review. French.
• Primum non nocere: An updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes.

  Fortuni F, Crimi G, Gritti V, Mirizzi AM, Leonardi S, Ferrari GM. Fortuni F, et al. Eur J Prev Cardiol. 2019 Oct;26(15):1677-1679. doi: 10.1177/2047487319826439. Epub 2019 Feb 11. Eur J Prev Cardiol. 2019. PMID: 30744399 No abstract available.